Arnesen H - Search Results

1

Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease.

Eritsland J, Arnesen H, Seljeflot I, Kierulf P. Eritsland J, et al. Among authors: arnesen h. Blood Coagul Fibrinolysis. 1995 Feb;6(1):17-22. doi: 10.1097/00001721-199502000-00003. Blood Coagul Fibrinolysis. 1995. PMID: 7795149 Clinical Trial.

2

Plasma free-fatty-acids and small doses of subcutaneous heparin in acute myocardial infarction.

Arnesen H, Bjerkedal I, Skjaeggestad O, Godal HC. Arnesen H, et al. Thromb Res. 1979;14(4-5):541-9. doi: 10.1016/0049-3848(79)90110-5. Thromb Res. 1979. PMID: 483254 Clinical Trial. No abstract available.

3

Introduction: the metabolic cardiovascular syndrome.

Arnesen H. Arnesen H. J Cardiovasc Pharmacol. 1992;20 Suppl 8:S1-4. doi: 10.1097/00005344-199200208-00001. J Cardiovasc Pharmacol. 1992. PMID: 1283761

4

Effects of long-term treatment with warfarin on fibrinogen, FPA, TAT, and D-dimer in patients with coronary artery disease.

Eritsland J, Seljeflot I, Arnesen H, Smith P, Westvik AB. Eritsland J, et al. Among authors: arnesen h. Thromb Res. 1992 Apr 1;66(1):55-60. doi: 10.1016/0049-3848(92)90155-4. Thromb Res. 1992. PMID: 1412183 Clinical Trial.

5

Effects of long-term anticoagulant therapy in subgroups after acute myocardial infarction.

Smith P, Arnesen H, Abdelnoor M. Smith P, et al. Among authors: arnesen h. Arch Intern Med. 1992 May;152(5):993-7. Arch Intern Med. 1992. PMID: 1580727 Clinical Trial.

6

The predictability of bleeding by prothrombin times sensitive or insensitive to PIVKA during intensive oral anticoagulation.

Arnesen H, Smith P. Arnesen H, et al. Thromb Res. 1991 Feb 1;61(3):311-4. doi: 10.1016/0049-3848(91)90108-9. Thromb Res. 1991. PMID: 1822957

7

The effect of warfarin on mortality and reinfarction after myocardial infarction.

Smith P, Arnesen H, Holme I. Smith P, et al. Among authors: arnesen h. N Engl J Med. 1990 Jul 19;323(3):147-52. doi: 10.1056/NEJM199007193230302. N Engl J Med. 1990. PMID: 2194126 Free article. Clinical Trial.

8

Effects of gemfibrozil on lipids and haemostasis after myocardial infarction.

Andersen P, Smith P, Seljeflot I, Brataker S, Arnesen H. Andersen P, et al. Among authors: arnesen h. Thromb Haemost. 1990 Apr 12;63(2):174-7. Thromb Haemost. 1990. PMID: 2194314 Clinical Trial.

9

Warfarin has no negative impact on fibrinolysis.

Smith P, Arnesen H, Opstad T, Kierulf P. Smith P, et al. Among authors: arnesen h. Thromb Res. 1990 Jun 15;58(6):653-6. doi: 10.1016/0049-3848(90)90311-y. Thromb Res. 1990. PMID: 2201102 Clinical Trial. No abstract available.

10

Influence of highly concentrated n-3 fatty acids on serum lipids and hemostatic variables in survivors of myocardial infarction receiving either oral anticoagulants or matching placebo.

Smith P, Arnesen H, Opstad T, Dahl KH, Eritsland J. Smith P, et al. Among authors: arnesen h. Thromb Res. 1989 Mar 1;53(5):467-74. doi: 10.1016/0049-3848(89)90201-6. Thromb Res. 1989. PMID: 2660319 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results